<unk>  is an immunologic adjuvant that is FDA approved for the prophylaxis of tuberculosis in persons not previously infected with M. tuberculosis who are at high risk for exposure.   Common adverse reactions include percutaneous injection site reaction, nausea, axillary or cervical lymphadenopathy, , induration, cystitis, dysuria, hematuria, increased frequency of urination, urgent desire to urinate, influenza-like illness, malaise, shivering.
BCG vaccine
MMR vaccine
Polio vaccine
Smallpox vaccine
Childhood vaccination schedule
Ebola vaccines
Zoster vaccine
Influenza vaccine